As the CEO of Turing Pharmaceuticals, Martin Shkreli was all over television as a self-proclaimed hero of free-market health care, when he legally bought the rights to a life-saving drug which had been on the market for 53 years. He then immediately raised the price from $13.50 a pill to $750 a pill.